Nuvalent (NUVL) Equity Ratio (2020 - 2026)

Nuvalent (NUVL) reported Equity Ratio of 0.88 for Q1 2026, down 3.51% on a YoY basis from 0.91 in Q1 2025, and little changed quarter-over-quarter from 0.88 in Q4 2025.

Nuvalent (NUVL) Equity Ratio (2020 - 2026) Analysis & Trends

Nuvalent has reported Equity Ratio for 7 years, with the latest figure at 0.88 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 3.51% year-over-year to 0.88; the trailing twelve-month figure through Mar 2026 stood at 0.88 (down 3.51% YoY), and the FY2025 full-year result was 0.88, down 5.69% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.88, roughly flat from 0.88 in the prior quarter.
  • The five-year high for Equity Ratio was 0.97 in Q1 2022, with the low at 0.86 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.93 across 5 years, with a median of 0.94 in 2024.
  • Annual changes were most pronounced in 2022 — Equity Ratio surged 389.12% — and 2025, when it declined 8.51%.
  • Nuvalent's Equity Ratio stood at 0.96 in 2022, then dropped by 0.32% to 0.96 in 2023, then fell by 2.05% to 0.94 in 2024, then slipped by 5.69% to 0.88 in 2025, then fell by 0.16% to 0.88 in 2026.
  • The last three Equity Ratio figures came in at 0.88 (Q1 2026), 0.88 (Q4 2025), and 0.86 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 191.07
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 0.98
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 0.04
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.58
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 0.42
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 0.73
9 Abivax 91.71 Bn 91.71 Bn - 0.79
10 Nuvalent 9.70 Bn 9.70 Bn - 0.88

Historic Data

Download Data
DateValue
Mar 31, 2026 0.88
Dec 31, 2025 0.88
Sep 30, 2025 0.86
Jun 30, 2025 0.90
Mar 31, 2025 0.91
Dec 31, 2024 0.94
Sep 30, 2024 0.94
Jun 30, 2024 0.94
Mar 31, 2024 0.95
Dec 31, 2023 0.96
Sep 30, 2023 0.93
Jun 30, 2023 0.95
Mar 31, 2023 0.96
Dec 31, 2022 0.96
Sep 30, 2022 0.95
Jun 30, 2022 0.96
Mar 31, 2022 0.97
Dec 31, 2021 0.97
Sep 30, 2021 0.98
Jun 30, 2021 -0.33